A managing director of investments at Wedbush Securities, Inc., Allison Clago leverages more than 30 years of experience in guiding families and businesses toward financial freedom. In addition, Allison Clago serves on the board of governors for the Providence Tarzana Medical Center Foundation.In April 2018, Providence Tarzana Medical Center, a leading source of quality care in San Fernando Valley, announced that it is the first medical facility in the area to offer the innovative TransCarotid Artery Revascularization (TCAR) procedure to patients. This procedure treats carotid artery disease using minimally invasive technology. In doing so, it reduces patients’ risk of stroke resulting from carotid artery disease.According to the hospital, roughly 15 million people throughout the world have a stroke each year. Of these, five million patients are disabled because of their stroke and six million of these strokes are fatal. It’s estimated that one-third of all stroke cases are related to carotid artery disease, a condition that is diagnosed in about 400,000 new patients in the US each year.In the past, treating carotid artery disease required patients to undergo a carotid endarterectomy, an open surgical procedure that leaves a long scar on the neck. Beyond affecting the patient's appearance, the procedure was also associated with such risks as nerve injuries, bleeding, infection, and heart attack. Many of these risks do not exist or are substantially reduced with the TCAR procedure because of its minimally-invasive nature. Surgeons using TCAR are capable of diverting clots caused by carotid artery disease by reversing blood flow through the trans-carotid artery. This allows surgeons to stabilize artery blockages using a stent inserted in this large blood vessel.
Allison Clago is the managing director of investments for Wedbush Securities in Los Angeles. A committed philanthropist and breast cancer survivor, Allison Clago gives back to her community by working as a member of the board of directors of the Providence Tarzana Foundation.The Providence Tarzana Medical Center has been serving the residents of the San Fernando Valley since 1973. The award-winning, 249-bed hospital has been named one of the Top 100 healthcare centers in the country by HealthGrades for the past two years.The Providence Tarzana Medical Center plans to build on this rich tradition by significantly expanding and improving its services and facilities in the near future. The project, dubbed “Tarzana Reimagined,” will enlarge the emergency, neonatal, and women’s health departments while adding physical improvements such as gardens on the hospital grounds. The Providence Tarzana Foundation is leading the fundraising efforts for the project, with a goal of $540 million. The initiative received a major boost in January of 2018, when Allison Clago, a Tarzana native, formally initiated a multimillion-dollar trust that will provide ongoing financial support to the hospital.
Possessing more than 30 years of experience as a financial professional, Allison Clago assists clients in a variety of areas, including asset allocation, investment analysis, retirement planning, and college funding. Since 2016, she has worked with clients as managing director of investments at Wedbush Securities, Inc., in Los Angeles. Outside of the office, Allison Clago is a major contributor to organizations such as the Alzheimer’s Association of California Southland Chapter. In addition to offering a range of patient and family support programs and resources, the Alzheimer’s Association leads the country’s research efforts to develop new methods for preventing, diagnosing, and treating Alzheimer’s disease and related dementias. Currently, the organization is preparing to host the Alzheimer’s Association International Conference (AAIC), which will bring together international research investigators, clinicians, and health care providers for the world’s largest forum for dementia study. AAIC 2018 will take place July 22-26 in Chicago. The main highlight of the five-day event will be an educational program comprising workshops, poster presentations, and scientific sessions led by top dementia researchers from around the globe. The conference will also include keynote presentations from several distinguished speakers, including Lennart Mucke, MD, Miia Kivipelto, PhD, and Guojun Bu, PhD. In addition to learning about the latest developments in dementia research and care, AAIC 2018 attendees will have an opportunity to explore new products and technologies at an exhibit hall. The event will also include an awards program celebrating the work of distinguished Alzheimer’s researchers. Additional information is available at www.alz.org/aaic.
